Healthcare Press Releases – Healthcare Press Releases

The Rising Concern with Pixie Ear Deformity and Solutions

before and after

The tightening of lower face, visible scars, a distorted hairline, and “pixie ear” deformity can be improved with correct positioning of the ears. The key is relying on the strength of the skull.”

— Dr. Daniel Man

MIAMI BEACH, FLORIDA, UNITED STATES, October 23, 2021 /EINPresswire.com/ — The holiday season is upon us and everyone wants to feel their best with a fresh facelift, without ending up looking like The Grinch or Tinkerbell. What many cosmetic surgeons don't realize is that when they operate on an older population doing facelifts, they actually cause an earlobe deformity called 'pixie ear' or the stretched out, elongated look of the ear that's lowered from its natural position.

Dr. Daniel Man, located in Boca Raton performed 106 facelifts using fat injections to improve the end result in 70% of cases, and the advantages of his technique include shorter incisions, a diminished need to remove redundant skin, ear elevation, and a smoother repair with improved contour.

Man wrote a study on the issue and says, "The telltale signs associated with facelift procedures, including tightening of the lower face, visible scars, a distorted hairline, and the 'pixie ear' deformity are grounds for concern among both patients and aesthetic surgeons. Facelift results can be improved with correct positioning of the ears, so signs are reduced or eliminated altogether. The key is relying on the strength of the skull, a bone, as a permanent stitch, which is the true solution."

Why is it so difficult to fix 'pixie ear' once the facelift is done? Attempts to tighten the SMAS (facial muscular system) to the surrounding area with vertically- or horizontally-oriented vectors causes further distortion of the ear. This deformity can be seen before placement of the last suture in the classical facelift technique, while the patient is still on the operating table and gravity worsens the deformity, which means that the ear worsens post-op, after patients get the procedure done.

In Man's method, the flaps are elevated, midface volume is augmented with fat and the bottom of the ear is elevated relative to its pre-op position. A face with more volume and ears positioned higher requires less skin removal, allowing the use of shorter incisions hidden mostly inside the ear, with no distortion of the hair lines and most importantly, possibly less scars, for a smoother repair, improved contour, and a more natural look.

For more information, please visit https://drman.com/

Jane Goey
Ameerah PR
+1 404-954-0858
email us here

Source: EIN Presswire

Spatz Medical Announces FDA Approval of Spatz3 Gastric Balloon, the First Adjustable Gastric Balloon

Dr. Jeffrey Brooks, Founder of Spatz-FGIA Inc

The Spatz3 Gastric Balloon

Spatz3 is the fifth balloon to receive FDA approval and its pivotal FDA clinical trial results demonstrated a 15% decrease in weight and an 84% success rate.

The Spatz adjustability function has raised the bar for gastric balloons and has resulted in impressive weight loss results and an outstanding 84% success rate.”

— Dr. Jeffrey Brooks

FORT LAUDERDALE, FLORIDA, UNITED STATES, October 23, 2021 /EINPresswire.com/ — Spatz Medical Announces FDA Approval of Spatz3 Gastric Balloon, the First Adjustable Gastric Balloon

• Excellent weight loss results in FDA clinical trials:
– 15% decrease in weight
– 84% success rate
• Safe and effective weight loss solution in more than 40 countries with almost 100,000 placements worldwide

Spatz FGIA, Inc., an international pioneer in gastrointestinal weight loss solutions, today announced that the U.S. Food and Drug Administration (FDA) has approved the Spatz3 Gastric Balloon, the first adjustable gastric balloon system, to aid in weight loss for adult patients struggling with obesity. The Spatz3 is the fifth balloon to receive FDA approval and its pivotal FDA clinical trial results demonstrated a 15% decrease in weight and an 84% success rate.

Although new to the United States, the Spatz Balloon has already been implanted in almost 100,000 patients in over 40 countries and as shown in the FDA study, its distinctive and unique adjustability feature has created an effective and safe weight loss therapy.

The Spatz3 Adjustable Gastric Balloon Innovation

Dr. Jeffrey Brooks, inventor of the Spatz3 adjustable balloon and CEO of Spatz FGIA, Inc. said, “We are proud of our FDA clinical trial results and look forward to bringing this proven technology to the U.S. population. FDA clinical trials are among the most respected because they are performed under stringent conditions – I.T.T., or intention to treat. This means every patient that is treated is accounted for and cannot be lost to follow-up, offering a true representation of results. The Spatz adjustability function has raised the bar for gastric balloons and has resulted in impressive weight loss results and an outstanding 84% success rate.”

Like other gastric balloons, the Spatz3 is inserted endoscopically while under conscious sedation. During the 15-minute non-surgical procedure, the balloon is placed in the stomach and inflated with saline, and the patient is discharged within one hour.

In the last four decades, the world has seen over 500,000 gastric balloons implanted and that experience, as documented in the medical literature, has taught us that almost all gastric balloon systems lose efficacy by the fourth month, leading to weight loss plateau and weight regain while the balloon is implanted. In addition, abundant medical publications have reported that approximately one in ten gastric balloon patients face premature extraction in the first month due to intolerance, characterized by persistent nausea, vomiting or abdominal pain.

These two issues are addressed by the proprietary adjustment feature of the Spatz balloon, which enables the physician endoscopist the ability to change the balloon volume at any time during the treatment period. The balloon volume adjustment is performed in a 15-minute outpatient endoscopic procedure and is used in the following two scenarios:
• A “down adjustment” to remove 100-150 ml from the balloon to alleviate intolerance and prevent early extraction
• An “up adjustment” to add 200-300 ml to the balloon, which rejuvenates the balloon effect and affords the second round of weight loss

Find out more: spatzmedical.com/about/how-it-works/

The Spatz3 Balloon has garnered significant applause from the medical community and its respected members, including Professor Barham Abu Dayyeh MD, MPH (Professor of Medicine, Director of Advanced Endoscopy, and Vice Chair of Innovation for the Department of Medicine at the Mayo Clinic). Professor Abu Dayyeh said, “A different paradigm is emerging for the management of obesity…to improve or resolve obesity-associated comorbidities. The adjustability feature of the Spatz3 balloon and longer treatment duration maximizes patients’ tolerance and uniquely positions this technology to offer a safe and effective modality to manage obesity in conjunction with a robust lifestyle intervention program.”

Spatz3 FDA Pivotal Clinical Study Results

In the U.S. pivotal Spatz3 clinical trial, 288 patients suffering from obesity (Body Mass Index 30-40 kg/m2) were randomized to treatment or control, with two-thirds randomized to implantation with the Spatz balloon with diet and exercise and one third serving as control patients on diet and exercise alone. During the 14-month pivotal trial all study endpoints were met.

Detailed findings of the trial revealed:
• Spatz Balloon patients lost 15% of their initial weight compared with 3% weight loss in the control group – five times greater weight loss with Spatz3 Balloon.
• Weight maintenance was measured for six months after balloon removal, with 74.3% achieving the weight loss maintenance endpoint.
• The adjustment feature was used to reduce balloon volume for intolerant patients. Twenty-eight intolerant patients underwent down adjustments with removal of 150 ml. Intolerance was alleviated in 82% of these patients, allowing them to complete the entire 8-month treatment period.
• At week 18 (+/- 4 weeks) up adjustments were performed in 71.7% of patients with the addition of 200-300 ml, resulting in additional loss of 15.2% of their excess weight after the 18-week adjustment.
• The overall success rate, defined as achieving at least 10% weight loss, was achieved in 84% of patients.

For more information about Spatz Medical, please visit spatzmedical.com.

###

About Spatz Medical
Spatz FGIA, Inc. develops and markets the Spatz3, an all-new category of Adjustable Gastric Balloon for the treatment of obese and overweight patients.* The Spatz3's exclusive adjustability feature delivers the highest success rates (response rates) on the market and brings new opportunities to the field of gastroenterology and bariatric endoscopy, enabling physician endoscopists to change the balloon volume at any time during the treatment period. This presents a solution for patients who are intolerant to gastric balloons, as well as a means of rejuvenation for patients whose weight loss has reached a plateau. Spatz, a global leader in its category, proudly offers its innovative technologies to over 40 markets worldwide and has implanted its balloons in almost 100,000 patients.

*Approved for use in adults with obesity Body Mass Index (BMI) of 35.0-40.0 kg/m2 or a BMI of 30.0 to 34.9 kg/m2 with one or more major obesity-related comorbid conditions who have failed to achieve and maintain weight-loss with a supervised weight control program.

For more information regarding Spatz3, please visit:
www.SpatzMedical.com

Ariel Nezry
Spatz FGIA, Inc.
+972 50-243-9391
email us here
Visit us on social media:
Facebook
LinkedIn

Spatz3 Introduction Movie

Source: EIN Presswire

Smart Syringe Market Size to Generate $ 14.18 Billion by 2027 | Growth & Key Business Strategies

Smarts Syringe

The market is driven by rise in count of needle stick injuries, shift from conventional syringes to smart syringes, growth in awareness in emerging economies

PORTLAND, OR, UNITED STATES, October 23, 2021 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND (Smart Syringes Market to Set New Growth Cycle)

Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulate unsafe injection practices. The factors driving the market growth include, rise in the number of needle stick injuries and surge in awareness about smart syringes. Further, shift in focus toward the use of innovative techniques for manufacturing smart syringes is expected to supplement the market growth throughout the forecast period. On the other hand, factors such as high cost along with unaffordable prices of safety syringes, and alternative modes of drug delivery restrict the market growth.

The global smart syringe market was valued at $6.8 billion in 2019 and is estimated to reach $14.18 billion by 2027 at a CAGR of 8.7% from 2020 to 2027. North America was the highest contributor to the smart syringe market in 2019, while, Asia-Pacific is expected to witness the highest growth during the forecast period. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Covid-19 Scenario:

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/838

Based on product, the active safety syringes segment occupied the largest share in the global market. It is anticipated to remain dominant during the forecast period owing to its cost-effectiveness, ease-of-use, and optimum protection to patients and healthcare employees by reducing the risk of needle sick injuries.

Based on application, vaccination is the fastest growing segment owing to the high demand for immunization service administered to pediatrics and neonates across the world.

Depending on age group, the adult segment occupied the largest share, which was attributed to growth in adult population that was infected by unsafe use of syringes.

Based on region, North America occupied the largest share, which was attributed to a well-established healthcare infrastructure along with rise in adoption of safety syringes owing to high buying power and stringent safety regulations. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in needle stick injuries, rise in awareness by regulatory bodies such as WHO, UNICEF, & others, and improvement in health standards.

The Major Key Players Are:

• Cardinal Health
• Unilife Corporation
• B. Braun Melsungen AG
• Becton
• Baxter International
• Gerresheimer AG
• Dickinson and Company
• Terumo Medical Corporation
• Smiths Group plc
• Retractable Technologies, Inc.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/838

The Other Prominent Players Are:

• L.O.M. Medical International
• Techcon
• Tecan Trading AG
• Meissner Filtration Products, Inc.
• ARxIUM
• Parker Hannifin Corporation.

Key Finding of the Smart Syringe Market:

• Based on end user, the psychiatric segment is projected to grow at the highest rate during the analysis period.
• North America dominated the global smart syringe market in 2017 and is projected to continue this trend in future.
• China is expected to grow at the highest rate in Asia-Pacific during the forecast period.
• Based on age group, the adult segment was the largest revenue contributor in 2017.
• The drug delivery segment generated the highest revenue and is expected to remain dominant in the future.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Biohazard Trash Cans Market Analysis, Industry Forecast, 2030

Bone-Cutting Technologies Market Analysis, Industry Forecast, 2030

Boxcar Scars Market Analysis, Industry Forecast, 2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Trauma Devices Market 2021: Expeditious Growth Expected In Coming Years – Claims Allied Market Research

Trauma Devices Market

Increase in the aging population which is highly prone to osteoarthritic fractures, increasing incidence rate of osteoporosis and technological advancements such as use of orthobiologic products”

— Allied Market Research

PORTLAND, OR, UNITED STATES, October 23, 2021 /EINPresswire.com/ — Trauma devices are one of the various clinical procedures used for the treatment of trauma based upon the severity of injury. Trauma refers to any kind of physical injury such as fractures, dislocations, sprains & strains and burns caused by any external source. According to Center for Disease Control and Prevention, Trauma is an injury or wound to a living individual caused by due to violence or external force. These devices are used in case of fractures, especially in the long bones.

Increase in the aging population which is highly prone to osteoarthritic fractures, increasing incidence rate of osteoporosis and technological advancements such as use of orthobiologic products and biodegradable materials will drive the market growth in the coming years. In addition, increase in the number of road accidents, sports related injuries and changing lifestyle of the people will further drive the market growth. Recently, 42 million trauma cases were observed in U.S. which eventually increased the demand for trauma devices. However, high cost of trauma devices, allergy associated with internal fixation devices and chances of infection are expected to impede the market growth.

Explore Report Description@ https://www.alliedmarketresearch.com/trauma-devices-market

Trauma Devices Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly.

The Covid-19 (corona virus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Trauma Devices globally. This report on ‘Trauma Devices’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast, factoring the impact of Covid -19 Situation.

Trauma Devices Market Competitive Analysis:

Arthrex, Inc., CONMED Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Stryker Corporation, Integra Lifesciences Holdings Corporation, Zimmer Biomet Holdings, Inc., Bioretec Ltd., Wright Medical Group N.V. and Advanced Orthopaedic Solutions, Inc… Provided in this report. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.

Trauma Devices Market Segmentation:

The research offers a detailed segmentation of the global Trauma Devices market. Key segments analyzed in the research by basis of product type, composition and geography. Based on product type trauma devices are of two types: internal fixation and external fixation devices. Internal devices are further segmented as intramedullary nails, plates and screws, cannulated screws and compression hip screws. External devices are further segmented as circular fixation, unilateral fixation and hybrid fixation devices. By composition, trauma devices can be classified into metallic fixators and bioabsorbable fixators End Users and geography. Extensive analysis of sales, revenue, growth rate, and market share of each for the historic period and the forecast period is offered with the help of tables.

Inquiry for Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/1543

Trauma Devices Market Regional Analysis:

The market is analyzed based on regions and competitive landscape in each region is mentioned. Regions discussed in the study include North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). These insights help to devise strategies and create new opportunities to achieve exceptional results.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Cell Counting Market Global Research By 2030

Allergy Diagnostic Market Global Research By 2030

Bioburden Testing Market Global Research By 2030

About Us:

David Correa
Allied Analytics LLP
8007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Cancer Vaccines Market is Generating Revenue of $ 7.30 Billion by 2027, at CAGR 12.6% Growth Rate

Cancer Vaccines Industry

Growth of the market is attributed to rise in number of cancer patients across the globe. rise in public awareness toward benefits of cancer vaccines

PORTLAND, OR, UNITED STATES, October 23, 2021 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND (Cancer Vaccines Market to Set New Growth Cycle)

Cancer vaccine is a type of immunotherapy that boosts the natural defense of body by stimulating the immune system to recognize and cure cancerous cells. Vaccines include antigenic components, which strengthens an individual’s immune system by developing adaptive immunity to prevent morbidity from infections. Moreover, cancer vaccines have been developed as a new beneficial way for cancer prevention & eradication. Currently, a wide range of cancer therapeutic vaccines are available in the market to effectively fight against cancer.

The global cancer vaccines market was valued at $ 4.18 billion in 2019, and is projected to reach $ 7.30 billion by 2027, registering a CAGR of 12.6% from 2020 to 2027. The recombinant cancer vaccines segment accounted for one-third share of the global market in 2019. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Covid-19 Scenario:

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1453

The cancer vaccines market is expected to experience a significant growth during the forecast period, owing to rise in demand for novel cancer vaccine products, increase in prevalence of HPV infections, surge in public awareness toward cancer diseases, and rise in investments by government & private organizations for production of new cancer vaccines. Moreover, rise in adoption rates of preventive and therapeutic vaccines, technological advancements in cancer vaccines, increase in number of cancer cases, and launch of novel cancer vaccines further boost the cancer vaccines market growth. However, high cost for developing cancer vaccines and longer time span required for manufacturing a single vaccine are anticipated to restrict the market growth. Furthermore, growth in transition from prophylactic to therapeutic cancer vaccines is expected to offer lucrative opportunities in the near future.

The global cancer vaccines market is segmented on the basis of technology, type, indication, end user, and region. On the basis of technology, the cancer vaccines market is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. The recombinant cancer vaccines segment dominated the global market in 2019, and is expected to maintain its dominance throughout the forecast period. This is attributed to large number of approved cancer vaccines developed using recombinant technology such as Cervarix, and Gardasil.

On the basis of indication, the cancer vaccines market is classified into cervical cancer, prostate cancer, and others. The cervical cancer segment accounted for maximum market revenue in 2019, and is anticipated to maintain its dominant position during the forecast period, owing to increase in number of people suffering from human papilloma virus (HPV) infections. In addition, high prevalence of cervical cancer drives the market growth. However, prostate cancer is expected to grow at the highest CAGR of 14.10% from 2020 to 2027, owing to the rise in demand for Provenge (prostate cancer vaccine) along with increase in number of prostate cancer vaccines in the pipeline.

North America accounted for the largest share of the global cancer vaccines market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to higher adoption of cancer vaccines, higher number of R&D activities to develop cancer vaccines, large number of target population with higher health awareness, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system. Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly owing to growth in prevalence of cancer with increase in demand for new cancer vaccines

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1453

The major companies profiled Are:

Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc (GSK), Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Sanpower Group Co. Ltd. (Dendereon Corporation), UbiVac, and Vaccinogen, Inc.

The other key players Are:

Gritstone Oncology, PaxVax Corporation., Bavarian Nordic, Bharat Biotech., VBI Vaccines Inc., Novavax, Inc., Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Galena Biopharma, Emergent Biosolutions, Prokarium, and ImmunoBiology Ltd.

Key Findings of the Study:

• By technology, the recombinant cancer vaccines segment held the largest market share in 2019, and is expected to remain dominant throughout the forecast period.
• On the basis of type, the preventive cancer vaccines segment held the largest market share in 2019, and is expected to remain dominant throughout the forecast period.
• On the basis of indication, the cervical cancer segment held the largest market share in 2019, and is expected to remain dominant throughout the forecast period
• On the basis of end user, the pediatrics segment exhibits fastest growth, and is expected to grow at a CAGR of 13.0% from 2020 to 2027.
• Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 15.0% during the forecast period.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Antimicrobial Regenerative Wound Matrix Market Industry Forecast, 2030

Automated Clinical Analyzers Market Analysis, Industry Forecast, 2030

Biochemistry Analyzers Market Analysis, Industry Forecast, 2030

About Us

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Cosmetic Laser Market Size to Gain Traction of $ 5.41 Billion, Growth Opportunities by 2026

Cosmetic Lasers

The considerable surge in the preference for non-aesthetic procedures and technical advancements in laser technology are the major factors that drive the market

PORTLAND, OR, UNITED STATES, October 23, 2021 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND (Cosmetic Laser Market to Set New Growth Cycle)

Cosmetic lasers is a therapy used to reduce facial wrinkles and skin irregularities, such as skin laxity, moles, liver spots, excess fat, and blemishes or acne scars. The technique directs short, concentrated pulsating beams of light on irregular skin, precisely removing skin layer by layer. This popular procedure is also called lasabrasion, laser peel, or laser vaporization. Cosmetic lasers have revolutionized the beauty industry and offers minimally invasive treatments. Different types of lasers use various wavelength for targeting different pigments. In addition, ablative lasers focus on outer layer of the skin and create micro wounds on the skin surface. Whereas, the non-ablative lasers pass safely through outer skin and breach the tissue lying below.

The global cosmetic laser market size is expected to reach $ 5,416.70 million by 2026, registering a CAGR of 14.5% from 2019 to 2026, in terms of value. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Covid-19 Scenario:

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5329

Technological advancements in cosmetic lasers such as providing minimally invasive treatments and surge in awareness among individuals toward self-grooming are the major factors that propel the cosmetic laser market growth. In addition, rise in disposable incomes in developing economies, such as China and India, further contribute to the growth of cosmetic laser market. However, high cost of these devices and a lack of appropriate reimbursement policies restrain the growth of cosmetic laser market. On the contrary, rise in baby boomer population and the budding trend of body altering across the globe are anticipated to create lucrative opportunities for the market in the future. In addition, manufacturers are continuously focused toward improving their products to help users gain better results in a shorter time period with minimal or no incisions.

By type, the non-ablative segment accounted for 65% of the total cosmetic laser market share in 2018 and is expected to exhibit a prominent growth rate in the future, because these devices require small incisions on the skin surface through which a cannula is inserted. The laser energy is delivered to the target tissues through the cannula, which results in destruction of adipocytes by coagulation. In addition, currently, available laser-assisted devices include Smartlipo by Hologic, Inc. ProLipo PLUS by Sciton, Inc., and others.

Based on cosmetic laser market trend, the body contouring segment dominated the cosmetic laser market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in awareness among individuals toward self-grooming and getting their bodies in shape. Moreover, significant rise in obesity across the globe contributes to the cosmetic laser market growth. Further, body contouring devices are used to tighten lax skin or to remove undesired fat from various body parts, such as waist, abdomen, upper torso, and others. These devices work on different mechanisms such as radiofrequency, cryolipolysis, high-intensity focused ultrasound (HIFU), and others.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5329

The Major Key Players Are:

• Alma
• Candela
• Cutera
• Cynosure
• Deka
• Hoyoconbio
• Lumensis
• Palomar
• Syneron
• Aerolase El.En. Spa Lumenis Ltd.
• Aerolase Corporation
• Sciton, Inc.
• Sharp Light Technologies
• Fosun Pharmaceutical
• Syneron Medical Inc.
• Solta Medical.

The other Key players Are:

• Aerolase Corporation
• Iridex
• ALLTEC GmbH
• Fotona.

Key Findings of the Study:

• By type, the non-ablative segment accounted for the highest market share of 65% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
• By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
• By application, the body contouring segment is expected to grow at a CAGR of 14.4% during the forecast period.
• By end user, the hospital segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

12 Channel Electrocardiograph Market Analysis, Industry Forecast, 2030

Anterior Cervical Plating Market Analysis, Industry Forecast, 2030

About Us

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Biomarker Technologies Market to Generate $58.50 Billion by 2026 | Growth & Key Business Strategies

Biomarkers Technology

Rise in R&D activities and surge in prevalence of diseases such as various types of cancer, diabetes type 1, AIDS, rheumatoid arthritis, and others.

PORTLAND, OR, UNITED STATES, October 23, 2021 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND (Biomarker Technologies Market to Set New Growth Cycle)

Biomarker technologies are techniques that are used to find out biomarkers. These biomarkers are characteristics, genes, or molecules which are used to measure the biological parameters of the body. These biological parameters help in identification of various diseases and can also be helpful in drug discovery. Different technologies, which are used for the identification of biomarkers include next generation sequencing, polymerase chain reactions, immunoassays, and others. These techniques are utilized in various field of science and are mostly used in identification of different disease such as cancers, autoimmune diseases, infectious diseases, and others. Moreover, the use of biomarkers has revolutionized patient treatment, which has become more personalized leading to better treatment outcomes.

The global biomarker technologies market accounted for $ 21,594 million in 2018 is expected to reach $ 58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Covid-19 Scenario:

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/5293

The key factors that drive the growth of the global biomarker technologies market are rise in prevalence of various diseases such as cancer, autoimmune diseases, and others. The other factors that contribute toward the growth of the market include surge in research related to drug discovery and increase in healthcare expenditure. However, high initial investments for the discovery of biomarker can hamper the market growth to a certain extent. Whereas, surge in awareness associated with the need of early detection of various diseases such as cancers and high growth potential in emerging economies are anticipated to provide lucrative opportunities in the market during the forecast period.

On the basis of technology, the immunoassay segment was a major revenue contributor in 2018 and is expected to maintain its dominant position throughout the analysis period due to surge in prevalence of various diseases across the globe. For instance, the rise in prevalence of cancer contributes to the growth of biomarker technologies market as biomarkers serve as tools in diagnosis of cancer. Moreover, other diseases such as diabetes type 1, is highly prevalent worldwide. This factor contributes toward the growth of the biomarker technologies market. In addition, infectious diseases such as AIDS, tuberculosis, and others are also diagnosed using biomarkers.

The factors above mentioned are responsible for the growth of this segment. On the other side, next generation sequencing is expected to be the fastest growing segment during the forecast period as this technique is highly advantageous due to its property of differentiating between closely related tumor cells to provide better understanding of the growth of cancer. Moreover, the rise in research related to cancer worldwide is another factor that boosts the growth of this market.

According to product, the consumables segment accounted for the highest market share in 2018, and is anticipated to maintain this trend during the forecast period, as consumables form an important part of biomarker testing. Instrument segment is the fastest growing segment during the forecast period owing to the technological advancements.

In 2018, North America accounted for the major share of biomarker technologies market size and is expected to continue this trend owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced biomarker testing instruments and high prevalence of disease such as cancer, infectious diseases, neurological disorders, autoimmune diseases, and others. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5293

The major companies profiled Are:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• LI-COR, Inc.
• Merck KGAA
• PerkinElmer Inc.
• QIAGEN
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.

Key Findings of the Biomarker Technologies Market:

• Consumables occupied two-third share of the market in 2018.
• The next generation sequencing segment is anticipated to grow with the highest CAGR throughout the forecast period.
• The drug discovery segment accounted for half share of the global biomarker technologies market in 2018.
• The cardiovascular disorders segment is anticipated to grow at the highest rate during the analysis period.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Ambulance Stretchers Market Analysis, Industry Forecast, 2030

3D Drug Eluting Balloons Applications in Healthcare Market Forecast, 2030

About Us

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Knee Braces Market Size Estimated to Observe Significant Growth by 2027

Knee braces are medical tools that are primarily used for knee alignment, pain reduction in several medical conditions including tendonitis

PORTLAND, OREGON, UNITED STATES, October 23, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Knee Braces Market: Global Opportunity Analysis and Industry Forecast, 2020-2027". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Knee braces are medical tools that are primarily used for knee alignment, pain reduction in several medical conditions including tendonitis, osteoarthritis and other injuries and in maintaining functional and structural attributes of the knee. Knee braces also offer relief to patients suffering from meniscus injuries and aid in injury rehabilitation. The use of these orthopedic tools by athletes during sports activities offers prevention from various knee injuries, and help patients affected due to arthritis and to get rid of pain. Knee braces provide structural support to knee joints which helps to prevent injuries. Knee braces are made from combination of several flexible and rigid components including metal, moldable foam, plastic, padding, synthetic rubber or elastic material and straps. These medical tools are available in various sizes and variable provisions for adjustments of pressure. Customized knee braces are also available in the market designed for perfectly fitting the knee measurements.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/11223

Comprehensive competitive analysis and profiles of major market players, such as

3M Company, Becker Orthopedic, Chase Ergo Inc., Corflex Inc., BSN Medical GmbH, Medi Gmbh & Co. Kg, Remington Products Company, Pelican Manufacturing, Zimmer Biomet Holdings Inc. and Spring Loaded Technology Inc.

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Knee Braces Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Knee Braces Market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Knee Braces Market growth.

Table of Content:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Knee Braces Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Knee Braces Market in 2020?
Q4. Which is base year calculated in the Knee Braces Market report?
Q5. Does the Knee Braces Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Knee Braces Market?
Q7. Does the Knee Braces Market report provides Value Chain Analysis?
Q8. What are the key trends in the Knee Braces Market report?

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11223

Avenue Basic Plan | Library Access | 1 Year Subscription |

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Meniscal Repair Systems Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Metastatic Bone Disease Treatment Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

[2021-2027] Current Analysis of Microarray Analysis Market with New Business Opportunities

Microarray Analysis

Microarray analysis is a very important method that uses gene chips which can bind to over a thousand RNAs at a time.

PORTLAND, OREGON, UNITED STATES, October 23, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Microarray Analysis Market: Global Opportunity Analysis and Industry Forecast 2019–2027". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Microarray analysis is considered to be an important tool when it comes to the elucidation of molecular pathways that lie in the downstream of the key transcriptional regulators for the cardiac development and Coronary Heart Disease. Microarray analysis mainly monitors the gene regulation which results due to allelic variation.

Microarray analysis has a very correlative nature and remains one of the most reliable and powerful techniques for the examination of the genetic processes which underlie in the physiological variation.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/10579

Comprehensive competitive analysis and profiles of major market players, such as

Thermo Fisher Scientific, Inc.
Merck Sharp & Dohme Corp
Agilent Technologies, Inc.
Applied Micro Arrays
Molecular Devices
PerkinElmer Inc.
Illumina, Inc.
GE Healthcare
QIAGEN
Bio-Rad Laboratories Inc.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the Microarray Analysis Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Microarray Analysis Market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Microarray Analysis Market growth.

Table of Content:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Microarray Analysis Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Microarray Analysis Market in 2020?
Q4. Which is base year calculated in the Microarray Analysis Market report?
Q5. Does the Microarray Analysis Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Microarray Analysis Market?
Q7. Does the Microarray Analysis Market report provides Value Chain Analysis?
Q8. What are the key trends in the Microarray Analysis Market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Microcatheters Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Artificial Tendons and Ligaments Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Radiopharmaceuticals Market Growth Rate at a CAGR of 7% during 2021-2026

Radiopharmaceuticals Market

SHERIDAN, ALABAMA, UNITED STATES, October 23, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled “Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global radiopharmaceuticals market size exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 7% during 2021-2026.

Radiopharmaceuticals refer to radioisotopes bound to biological molecules that can target specific tissues, cells or organs in a human body. These radioactive drugs can be differentiated into four categories, namely, radiopharmaceutical preparation, kit for radiopharmaceutical preparation, radionuclide generator, and radiopharmaceutical precursor. These medicines help to diagnose various ailments, including abscess and infection, blood vessel diseases, bone marrow diseases, cancer and tumors, colorectal disease, and kidney, lungs and liver diseases.

Request Free Sample Report: https://www.imarcgroup.com/radiopharmaceuticals-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic.

Global Radiopharmaceuticals Market Trends:

The rising availability and acceptance of several cancer-specific targeted therapies and diagnostic tests is majorly fueling the global radiopharmaceuticals market. It is further supported by the increasing prevalence of target conditions across the globe. Additionally, the rising utilization of radiopharmaceuticals in neurological applications is contributing to the market growth. Rapid advancements in the diagnostics sector, the presence of favorable regulations, and increasing investments in research and development (R&D) activities to assess the side effects of therapies are other factors influencing the market growth positively.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/radiopharmaceuticals-market

Global Radiopharmaceuticals Market 2021-2026 Analysis and Segmentation:

Competitive Landscape with Key Player:

Advanced Accelerator Applications (Novartis AG)
Bayer AG
Bracco S.p.A.
Cardinal Health Inc.
Curium Pharma
General Electric Company
IBA RadioPharma Solutions
Jubilant Pharma Limited
Lantheus Medical Imaging Inc
Nordion Inc. (Sotera Health)
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp.
Siemens AG.

Breakup by Application:

Oncology
Cardiology
Neurology
Endocrinology
Others
Breakup by Product Type:

Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

Breakup by End-Use:

Hospitals and Clinics
Research Institutes
Diagnostic Centers

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Report:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Source: EIN Presswire